Enliven Therapeutics (ELVN) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ELVN Stock Alerts $18.38 +1.20 (+6.98%) (As of 12:45 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Enliven Therapeutics Stock Price Performance5 Day Performance+3.32%1 Month Performance+2.73%3 Month Performance+9.18%6 Month Performance+64.42%Year-To-Date Performance+30.56%1 Year Performance-5.09% Receive ELVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details ELVN Stock Chart for Monday, April, 29, 2024 ELVN Chart by TradingView Enliven Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$16.78$17.18+2.38%$17.52$16.16148,934 shs$804.20 million04/25/2024$17.49$16.78-4.06%$17.36$16.53602,668 shs$785.47 million04/24/2024$17.37$17.49+0.69%$17.94$17.15221,584 shs$818.71 million04/23/2024$17.62$17.37-1.42%$18.20$17.01368,498 shs$813.09 million04/22/2024$17.28$17.62+1.97%$17.99$16.87280,702 shs$824.79 million04/19/2024$17.67$17.28-2.21%$18.51$15.96763,125 shs$808.88 million Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$17.30$17.67+2.14%$18.27$16.76211,501 shs$827.13 million04/17/2024$18.69$17.30-7.44%$19.45$17.09186,911 shs$712.76 million04/16/2024$19.94$18.69-6.27%$20.60$18.59147,810 shs$770.03 million04/15/2024$21.08$19.94-5.41%$21.19$19.55745,161 shs$821.53 million04/12/2024$23.82$21.08-11.50%$24.20$20.00853,372 shs$868.50 million04/11/2024$19.82$23.82+20.18%$26.00$22.623.35 million shs$981.38 million04/10/2024$19.19$19.82+3.28%$21.16$17.99832,208 shs$816.58 million04/09/2024$18.30$19.19+4.86%$19.97$18.27140,495 shs$790.63 million04/08/2024$19.40$18.30-5.67%$19.49$17.7087,392 shs$753.96 million04/05/2024$18.60$19.40+4.30%$19.65$18.17230,632 shs$799.28 million04/04/2024$18.59$18.60+0.05%$19.45$18.50184,850 shs$766.32 million04/03/2024$18.80$18.59-1.12%$19.00$18.04129,028 shs$765.91 million04/02/2024$18.90$18.80-0.53%$19.08$17.35383,056 shs$774.56 million04/01/2024$17.59$18.90+7.45%$19.36$17.32285,762 shs$778.68 million03/29/2024$17.59$17.59$18.69$17.36196,400 shs$724.71 million03/28/2024$18.63$17.59-5.58%$18.69$17.36196,384 shs$724.71 million03/27/2024$17.61$18.63+5.79%$18.81$17.5084,205 shs$767.56 million03/26/2024$17.78$17.61-0.96%$18.41$17.3497,388 shs$725.53 million03/25/2024$18.48$17.78-3.79%$18.89$16.81170,032 shs$732.54 million03/22/2024$18.06$18.48+2.33%$18.99$17.50137,240 shs$764.15 million03/21/2024$19.21$18.06-5.99%$19.20$17.59158,300 shs$746.78 million03/20/2024$17.54$19.21+9.52%$19.50$16.71252,538 shs$794.33 million03/19/2024$12.64$17.54+38.77%$18.15$14.50666,612 shs$725.28 million03/18/2024$11.97$12.64+5.60%$12.98$11.6774,346 shs$520.89 million03/15/2024$11.54$11.97+3.73%$12.26$11.02643,091 shs$493.28 million03/14/2024$12.27$11.54-5.95%$13.11$11.3596,076 shs$475.56 million03/13/2024$12.75$12.27-3.76%$12.83$12.2479,511 shs$505.65 million03/12/2024$13.48$12.75-5.42%$13.59$12.16221,118 shs$525.43 million03/11/2024$14.87$13.48-9.35%$14.69$13.4161,508 shs$555.51 million03/08/2024$15.40$14.87-3.44%$15.87$14.4746,231 shs$612.79 million03/07/2024$15.45$15.40-0.32%$16.11$15.2853,207 shs$634.63 million03/06/2024$16.04$15.45-3.68%$16.43$15.1942,263 shs$636.69 million03/05/2024$16.67$16.04-3.78%$16.41$15.8529,860 shs$661.01 million03/04/2024$16.67$16.67$17.10$15.7248,423 shs$686.97 millionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/01/2024$15.97$16.67+4.38%$17.14$15.9655,164 shs$686.97 million02/29/2024$17.00$15.97-6.06%$17.29$15.87133,354 shs$658.12 million02/28/2024$17.68$17.00-3.85%$17.67$17.0068,068 shs$700.57 million02/27/2024$17.56$17.68+0.68%$18.02$16.6065,278 shs$728.59 million02/26/2024$16.53$17.56+6.23%$17.61$16.3178,377 shs$723.65 million02/23/2024$15.90$16.53+3.96%$16.84$15.8239,375 shs$681.20 million02/22/2024$16.16$15.90-1.61%$16.81$15.3366,156 shs$655.24 million02/21/2024$16.57$16.16-2.47%$16.33$15.1954,894 shs$665.95 million02/20/2024$16.79$16.57-1.31%$18.00$15.5935,708 shs$682.85 million02/19/2024$16.79$16.79$17.70$16.6874,800 shs$691.92 million02/16/2024$17.30$16.79-2.95%$17.70$16.6874,876 shs$691.92 million02/15/2024$17.17$17.30+0.76%$17.88$16.96169,686 shs$712.93 million02/14/2024$14.85$17.17+15.62%$17.31$14.89929,915 shs$707.58 million02/13/2024$16.62$14.85-10.65%$16.42$14.7998,798 shs$611.97 million02/12/2024$15.95$16.62+4.20%$16.98$15.2588,863 shs$684.91 million02/09/2024$15.41$15.95+3.50%$16.86$14.2161,960 shs$657.30 million02/08/2024$15.22$15.41+1.25%$16.35$14.6859,463 shs$635.05 million02/07/2024$15.73$15.22-3.24%$15.87$15.0685,707 shs$627.22 million02/06/2024$14.75$15.73+6.64%$15.79$14.2967,032 shs$648.23 million02/05/2024$15.41$14.75-4.28%$15.31$13.9685,947 shs$607.85 million02/02/2024$16.45$15.41-6.29%$15.99$15.03128,106 shs$635.05 million02/01/2024$15.70$16.45+4.75%$16.98$14.8981,626 shs$674.25 million01/31/2024$16.28$15.70-3.56%$17.32$15.70602,603 shs$643.70 million01/30/2024$16.55$16.28-1.63%$17.19$16.2041,965 shs$667.48 million01/29/2024$15.98$16.55+3.57%$16.72$15.2373,253 shs$678.55 million Related Companies: ARS Pharmaceuticals Stock Chart Tango Therapeutics Stock Chart Arcutis Biotherapeutics Stock Chart Sage Therapeutics Stock Chart 89bio Stock Chart ALX Oncology Stock Chart Tyra Biosciences Stock Chart OPKO Health Stock Chart Pliant Therapeutics Stock Chart Arcturus Therapeutics Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.